Performance of serum marker panels for liver fibrosis in chronic hepatitis C.
about
Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosisFour-dimensional flow magnetic resonance imaging in cirrhosis.Prediction of liver cirrhosis, using diagnostic imaging tools.Hepatic steatosis and fibrosis: Non-invasive assessment.New combined parameter of liver and splenic stiffness as determined by elastography in healthy volunteersNon-invasive detection of liver fibrosis: MR imaging features vs. MR elastography.Prediction of esophageal varices in patients with cirrhosis: usefulness of three-dimensional MR elastography with echo-planar imaging technique.Invasive and non-invasive diagnosis of cirrhosis and portal hypertensionNon-invasive diagnosis of hepatitis B virus-related cirrhosisNon-invasive assessment of liver fibrosis in chronic hepatitis C.A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Evolving therapies for liver fibrosis.Meta-analyses of FibroTest diagnostic value in chronic liver disease.A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI)Liver cirrhosisBiopsy-controlled liver fibrosis staging using the enhanced liver fibrosis (ELF) score compared to transient elastography.FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.Prospective Evaluation of FIBROSpect II for Fibrosis Detection in Hepatitis C and B Patients Undergoing Laparoscopic Biopsy.Relationship between hepatic CTGF expression and routine blood tests at the time of liver transplantation for biliary atresia: hope or hype for a biomarker of hepatic fibrosis.A biomarker panel for peripheral arterial disease.Diagnostic accuracy of noninvasive markers of liver fibrosis in patients with psoriasis taking methotrexate: a systematic review and meta-analysis.Validation of hepascore as a predictor of liver fibrosis in patients with chronic hepatitis C infection.Non-invasive markers associated with liver fibrosis in non-alcoholic fatty liver disease.Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarraySerological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon.Serum Levels of Annexin A2 as a Candidate Biomarker for Hepatic Fibrosis in Patients With Chronic Hepatitis B.Panel of three novel serum markers predicts liver stiffness and fibrosis stages in patients with chronic liver disease.Serum TGF-β, Serum MMP-1, and HOMA-IR as non-invasive predictors of fibrosis in Egyptian patients with NAFLDHepatic fibrosis: evaluation with semiquantitative contrast-enhanced CT.Accurate Prediction of Advanced Liver Fibrosis Using the Decision Tree Learning Algorithm in Chronic Hepatitis C Egyptian Patients.Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver diseaseEnhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.Present and future therapeutic strategies in non-alcoholic fatty liver disease.FibroMAX: towards a new universal biomarker of liver disease?Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and realitySystematic review and meta-analysis of the diagnostic accuracy of fibrosis marker panels in patients with HIV/hepatitis C coinfection.Hepatitis C infection with normal liver chemistry testsEvaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis CAssessing liver fibrosis.
P2860
Q21261905-B1F553D6-2986-462C-B8CB-1BF6C9BB7C47Q26769606-294D8E95-E7E0-40B3-B4A2-699AD88FB904Q26795413-9FE5C836-D451-4D5B-B044-89A3F0D708CEQ28077200-1455FC65-4821-4210-A2EF-90213A92BBA0Q30374817-02BB1CE8-4A52-4A0E-A834-51EE64FAAEE3Q30391776-215860D6-4355-46F6-9C19-23B3360ED8EBQ30415019-A2027652-D8FA-497C-B992-0231ED38B1B7Q30439743-293E6F83-691E-48AE-9880-5D8561D97D30Q30442641-0CB2A890-3FC4-43F9-948B-3E1064488FA3Q30474738-27565451-5537-4DEF-9C56-F3109F64C3E7Q30476922-FBA1B3A9-2911-4C90-AB02-EE6A7D8B4A13Q30539166-301FA83A-E8AF-4211-8972-2F890D2B3AF8Q33302708-199166CB-4145-4291-9EE4-4959D52F798EQ33877980-53EF02B3-55D1-46C8-8D00-0EDA6253ECC7Q34010340-BF821377-7E60-408A-ADAC-4483B8DEF9AFQ34532528-53E9D5D0-B5B2-4516-B42B-685E939065B1Q34686484-99744BC2-AF0A-4ADC-93C6-2280A58A8B67Q34996766-E7FD2659-08C5-4C05-A04C-2528D023F6FCQ35026403-8BC7D5DF-7B8D-465F-83F4-D45606316863Q35098249-3003C970-11BF-45DD-BE3B-046DF07DF880Q35109287-67D9D59D-97E8-41BC-84DB-DE3A4F3CD239Q35663973-1531BD81-C51A-47E8-9960-F88341A65E49Q35769146-233F24C5-F46C-47B3-A154-A1A9A48D419FQ35945962-808BCE42-E91C-4D4B-93F4-1B073CDB35D8Q36052963-D3E6333F-4550-4E1E-920F-999A828CDE8CQ36279439-6E498B68-BE64-4F29-9B5D-7A05C66512ADQ36310780-8CD9D2BB-CEF9-4FC3-8276-D30FEB504775Q36404882-560DCC84-8FDF-42E8-B3E0-1C344D67E269Q36484980-ED8F4547-0A46-4C79-A0CC-A81CD04EF6B5Q36530883-224451B7-FC76-4294-826C-40418AEC018DQ36643026-AE13D4F1-58C9-4E6E-8273-31C024575220Q36715064-6CC3B28F-EFBF-4914-B5FD-6C64B235F40EQ36914350-08D9C186-5C62-4AE5-94E3-34D2050D5995Q36936358-EB13C669-FB38-4EA1-BA1A-58C7325654A8Q36950410-7671C03E-08DF-4B84-A942-2950C20BB6D1Q36990696-56F6820A-807F-4E5C-B778-EA533C1DC3B1Q37063803-AD09EC85-EFD0-4568-B33D-B766750EFE38Q37137089-37F328FB-11B1-4B48-800F-D471D4B818A1Q37263883-BE259F66-CA29-4F90-9EA9-72AC08E16FE6Q37345958-367B9609-3B7E-499C-AC6B-41AF7F4F1260
P2860
Performance of serum marker panels for liver fibrosis in chronic hepatitis C.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Performance of serum marker panels for liver fibrosis in chronic hepatitis C.
@ast
Performance of serum marker panels for liver fibrosis in chronic hepatitis C.
@en
type
label
Performance of serum marker panels for liver fibrosis in chronic hepatitis C.
@ast
Performance of serum marker panels for liver fibrosis in chronic hepatitis C.
@en
prefLabel
Performance of serum marker panels for liver fibrosis in chronic hepatitis C.
@ast
Performance of serum marker panels for liver fibrosis in chronic hepatitis C.
@en
P1476
Performance of serum marker panels for liver fibrosis in chronic hepatitis C
@en
P2093
Julie Parkes
Paul Roderick
P304
P356
10.1016/J.JHEP.2005.10.019
P577
2005-11-21T00:00:00Z